Articles tagged "Outcome"

2021 American Transplant Congress
Tacrolimus Shortage and the Rush to Convert: An Unexpected Burden on the System During the Covid-19 Pandemic?
N. Pilch, L. Johnson, M. Aldoughaim, N. Patel, F. Bartlett
Medical University of South Carolina, Charleston, SC
*Purpose: A national shortage of immediate release (IR) tacrolimus (FK) fully impacted our center in May 2020. The conversion process was immediately challenging during the…
2021 American Transplant Congress
Clinical Course and Outcomes in Solid Organ Transplant Recipients with Covid-19
R. C. Jackson¹, S. Challa², A. Halim¹, N. Kelly³, D. Maluf⁴, K. Shetty³, Z. Lominadze³
¹Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, ²Internal Medicine, University of Maryland Medical Center Midtown, Baltimore, MD, ³Program in Transplantation, Department of Medicine, University of Maryland Medical System, Baltimore, MD, ⁴Program in Transplantation, University of Maryland Medical System, Baltimore, MD
*Purpose: We characterized the outcomes of COVID-19 in our population of solid organ transplant recipients (SOTRs). Since these individuals are immunocompromised, with multiple comorbidities, we…
2021 American Transplant Congress
How Should Acute T-Cell Mediated Rejection of Kidney Transplants be Treated?
F. Aziz¹, S. Parajuli², N. Garg², M. Mohamed², A. Djamali², D. Mandelbrot²
¹University of Wisconsin, Madison, WI, ²University of Wisconsin, Verona, WI
*Purpose: Many guidelines suggest treating acute T-cell mediated rejection (TCMR) of kidney allografts that is Banff grade I with steroids alone and Banff grade II…
2021 American Transplant Congress
Initial Experience with Single-port Robotic-assisted Kidney Transplantation
M. Eltemamy, A. Aminsharifi, Y. Lin, Z. Schwen, M. Abou Zeinab, V. Krishnamurthi, D. Goldfarb, A. Wee, J. Kaouk
Cleveland Clinic, Cleveland, OH
*Purpose: Early experiences with multi-port robotic kidney transplantation have demonstrated a potential reduction in complications and improved convalescence while maintaining equivalent functional outcomes relative to…
2021 American Transplant Congress
Recent Trends and Outcomes of Liver Transplantation for Non-alcoholic Steatohepatitis versus Alcohol Liver Disease in the United States: Obesity Might be Protective
K. Okumura, I. Lee, H. Sogawa, G. Veillette, D. John, T. Diflo, R. Bodin, D. Wolf, S. Nishida
Surgery, Westchester Medical Center/New York Medical College, Valhalla, NY
*Purpose: Nonalcoholic steatohepatitis (NASH) and alcohol liver disease (ALD) are rapidly growing indications for liver transplantation (LT). The recent trends and outcomes in NASH and…
2021 American Transplant Congress
Creating a Lung Transplant Program Search Tool Tailored to Patient Characteristics
W. T. McKinney¹, C. R. Schaffhausen¹, M. Bruin², S. Chu², J. Snyder³, M. Hertz⁴, M. Valapour⁵, B. Kasiske⁶, A. Israni¹
¹Hennepin Healthcare Research Institute, Minneapolis, MN, ²College of Design, University of Minnesota, Minneapolis, MN, ³Scientific Registry of Transplant Recipients, Minneapolis, MN, ⁴Medical School, University of Minnesota, Minneapolis, MN, ⁵Pulmonary Medicine, Cleveland Clinic, Cleveland, OH, ⁶Nephrology, Hennepin Healthcare, Minneapolis, MN
*Purpose: Criteria for selecting lung transplant candidates and donors vary between programs and evolve as clinical practice advances. This variation impacts patient outcomes and the…
2021 American Transplant Congress
Impact of Traveling for Transplant on Access to and Outcomes from Kidney and Liver Transplantation
K. Ross-Driscoll¹, R. Lynch¹, D. Axelrod², R. Patzer¹
¹Emory University, Atlanta, GA, ²University of Iowa, Ames, IA
*Purpose: Newly developed transplant referral regions (TRRs) can be used to understand how and why patients travel outside of their home transplant center to receive…
2021 American Transplant Congress
Liver Transplantation for Unresectable Colorectal Cancer Liver Metastases: A Multicenter Experience
L. I. Ruffolo¹, K. Sasaki², K. Tomiyama¹, A. Nair¹, M. Orloff¹, B. Al-Judaibi³, M. Levstik³, M. Laryea³, K. Dokus¹, J. Errigo¹, A. Moro², C. Quintini², K. Hashimoto², M. Fujiki², K. Menon², C. Kwon², T. Diago Uso², R. Hernandez-Alejandro¹, F. Aucejo²
¹Surgery, University of Rochester Medical Center, Rochester, NY, ²Surgery, The Cleveland Clinic Foundation, Cleveland, OH, ³Transplant Hepatology, University of Rochester Medical Center, Rochester, NY
*Purpose: Colorectal cancer is the third leading cause of cancer related death, unfortunately 50% of patients will develop colorectal liver metastases (CRLM), and a minority…
2021 American Transplant Congress
Acute Dialysis, Mortality and Renal Failure After Heart Alone Transplant by Egfr and Dialysis Requirement in the United States
M. Aljuhani¹, T. Alexy¹, S. Jackson², C. Martin¹, R. Kandaswamy³, S. Riad¹
¹Medicine, University of Minnesota, Minneapolis, MN, ²Complex Care Analytics, Fairview Health Services, Minneapolis, MN, ³Surgery, University of Minnesota, Minneapolis, MN
*Purpose: We examined the early acute dialysis, 90-day mortality and one-year ESRD among OHT recipients by eGFR and dialysis requirement before transplantation.*Methods: Utilizing the SRTR…
2021 American Transplant Congress
Pre-Transplant Frailty is Associated with 30-Day Mortality but Not Long-Term Survival After Liver Transplantation
M. Anderson, V. Valbuena, M. Englesbe, C. Sonnenday
Department of Surgery, University of Michigan Health System, Ann Arbor, MI
*Purpose: Frailty predicts waitlist death in liver transplant (LT) candidates, but the impact of frailty on mortality after LT is unknown. We investigated the association…